Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Celadon Laboratories

1999 FOUNDED
PRIVATE STATUS
51-60 EMPLOYEES
Grant LATEST DEAL TYPE
$1.1M LATEST DEAL AMOUNT
1 INVESTORS
Description

Developer of a cloud software for immunoassay development and manufacture. The company develops ImmūnQC, a web-based software platform and associated applications for immunoassay analysis, next-gen sequencing, oligo design, biomarkers, nanosensors and related technolgies.

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Social/Platform Software
Other Industries
Biotechnology
Other Healthcare
Primary Office
  • Suite 521
  • 6525 Belcrest Road
  • Hyattsville, MD 20782
  • United States

+1 (301) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Celadon Laboratories’s full profile, request a free trial.

Celadon Laboratories Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Grant 01-Jan-2013 $1.1M Completed Generating Revenue
3. Grant 01-Jan-2011 00000 Completed Generating Revenue
2. Grant 01-Jan-2007 $1.04M Completed Generating Revenue
1. Accelerator/Incubator 14-Aug-2006 Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

Celadon Laboratories Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Maryland Industrial Partnerships Accelerator/Incubator 000 0000 000000 0

Celadon Laboratories Executive Team (2)

Name Title Board
Seat
Contact
Info
Lawrence Kessner JD Chief Executive Officer

1 Former Executive

You’re viewing 1 of 2 executives. Get the full list »